Safety and Efficacy of Ketamine Without Intubation in the Management of Refractory Status Epilepticus: A Case Series

Author:

Kimmons Lauren1ORCID,Alzayadneh Mohammad2,Metter Jeffrey2,Alsherbini Khalid2

Affiliation:

1. Methodist University Hospital

2. The University of Tennessee Health Science Center

Abstract

Abstract Purpose: Continuous infusion ketamine has demonstrated efficacy in the management of refractory status epilepticus (RSE) yet does not suppress respiratory drive like other continuous infusion anesthetics used for this indication. Utilizing ketamine early in the management of RSE represents a treatment option with potential to reduce morbidity. The aim of this study is to describe the safety and efficacy of ketamine infusions in RSE patients without intubation. Materials and Methods: We analyzed a retrospective cohort of adult patients who were not intubated at the time of initiation of a ketamine infusion for RSE. Seizure onset was determined to be the first clinical seizure or non-convulsive seizure reported on electroencephalogram (EEG) or the start time of EEG for patients in RSE at EEG initiation. Responders were defined as patients with documentation of resolution of seizures within 24 hours of initiation without the need for intubation or additional continuous infusion anesthetics. Results: A total of 28 patients were analyzed of a median age 62 years, 64.3% female, 82.1% African American, and 82.1% with structural seizure etiology. 78.5% of patients received an initial bolus averaging 0.9 mg/kg and the majority (89.3%) were initiated on an infusion at 10 mcg/kg/min; median duration of infusion was 39.8 hours. 71.4% of patients were assessed to be ketamine responders; six of the eight non-responders required intubation and an additional continuous infusion anesthetic. Responders were 80% more likely to have received ketamine five or more hours earlier than non-responders. Hypotension (SBP < 90 mmHg) occurred in 31.8% of patients receiving only ketamine, which did not correlate with duration or maximum dose of ketamine. Conclusion: Ketamine represents a safe and effective treatment option for RSE with potential to reduce morbidity associated with intubation. Early initiation may increase likelihood of success.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3